Head and neck neuroendocrine tumors at a single institution over 15 years.

Autor: Bacalao M; Department of Medicine UT Southwestern Medical Center Dallas Texas., Beg MS; Division of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas., Cavuoti D; Department of Pathology UT Southwestern Medical Center Dallas Texas., Zhu H; Department of Clinical Sciences UT Southwestern Medical Center Dallas Texas., Sumer B; Department of Otolaryngology UT Southwestern Medical Center Dallas Texas., Myers L; Department of Otolaryngology UT Southwestern Medical Center Dallas Texas., Truelson J; Department of Otolaryngology UT Southwestern Medical Center Dallas Texas., Nedzi L; Department of Radiation Oncology UT Southwestern Medical Center Dallas Texas., Sher D; Department of Radiation Oncology UT Southwestern Medical Center Dallas Texas., Hughes R; Division of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas., Khan SA; Division of Hematology and Oncology/Harold C. Simmons Comprehensive Cancer Center UT Southwestern Medical Center Dallas Texas.
Jazyk: angličtina
Zdroj: Clinical case reports [Clin Case Rep] 2019 Nov 17; Vol. 7 (12), pp. 2508-2512. Date of Electronic Publication: 2019 Nov 17 (Print Publication: 2019).
DOI: 10.1002/ccr3.2545
Abstrakt: Head and neck cancer is a diverse group of rare diseases such as neuroendocrine tumors which can be thought of as extrapulmonary small-cell cancer. Surgery, chemotherapy, and radiation can frequently cure this disease, possibly due to early detection.
Competing Interests: None declared.
(© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje